The BioIndustry Association (BIA) has published new data showing that the UK’s life sciences sector...
NEWS
New 36-Month Efficacy and Safety Data for Leqembi (Lecanemab)...
Eisai has announced new 36-month (3-year) efficacy and safety results from its Phase 3 Clarity AD...
BioNTech commits £1 billion to UK research with £129 million...
BioNTech has announced a major expansion of its UK footprint, pledging to invest up to £1 billion...
UK biotech investment remains resilient in H1 2025, says BIA...
The UK’s biotech sector has demonstrated resilience in the first half of 2025, according to the...

